The
HIV Vaccines and Microbicides Resource Tracking Working Group was founded in 2004 to track global resources dedicated to the research and development of new biomedical tools for HIV prevention. The Working Group is a collaboration between
AVAC: Global Advocacy for HIV Prevention, IAVI, the
International Partnership for Microbicides, and the
Joint United Nations Programme on HIV/AIDS (UNAIDS). Funding data assembled by the Working Group date back to 2000 and have enabled the systematic tracking of investments and trends in the development of new tools and strategies to prevent HIV.
The most recent report, Investing to End the AIDS Epidemic: A new Era for HIV Prevention Research and Development (PDF), was issued in July 2012. It covers investments through 2011 on preventive and therapeutic vaccines against HIV, microbicides, adult male circumcision, female condoms, pre-exposure prophylaxis (PrEP), herpes simplex 2 prevention, prevention of mother-to-child vertical HIV transmission, from mother to child and treatment as prevention.
Global preventive HIV vaccine R&D investment totaled US$845 million in 2011, with the public sector providing US$702 million (83%), the philanthropic sector providing US$113 million (13%) and the commercial sector contributing US$30 million (4%). The 2011 total investment represents a decline of US$14 million (-2%) from global preventive HIV vaccine R&D investment in 2010.
The United States government remained the largest donor, despite a small decrease in its contributions in part accounted for in part by the end of domestic stimulus funding. Further, funding from European public sector agencies dropped significantly. Funding from new philanthropic supporters The overall decline in funding was offset somewhat by the contributions of new philanthropic supportersthe overall drop somewhat, and . eEstimates forof commercial funding, meanwhile, remained level. The HIV vaccine field has produced an abundance of promising data in recent years. B but, given the long-term nature of HIV vaccine development, itcontinued progress will requiredepend on flexible and sustained investments in research and development..
For more information on the Working Group, archived reports and materials, and information on its members, please visit http://www.hivresourcetracking.org.